QuantumSi Inc logo

QuantumSi Inc

QSI
Last price US$0.744
Market cap US$171.0m
12M price change -33.54%
Loading the 12-month Mave Thesis and 1-month news signal

Dashboard Funda..tals Prediction Screener Map

QuantumSi Inc Overview

Industry: Biotechnology

Sector: Healthcare

Read More

Mavefund brings filings, fundamentals, valuation, price history and news for QuantumSi Inc into one research view. The sections below show what strengthens or weakens the research case.

Score

Reported Results

What the company reported, with filing details kept small.

Filed Aug 13, 2026

Quarterly result summary

Revenue was $344 (-42% YoY). Net loss was -$23.5M (from $28.8M). Adjusted EBITDA was -$21.2M (-5% YoY).

Revenue $344 -42% YoY
Net loss -$23.5M from $28.8M
Adjusted EBITDA -$21.2M -5% YoY
Cash $169.9M reported

What changed

  • Revenue -42% YoY to $344.
  • Net loss was -$23.5M (from $28.8M).
  • Adjusted EBITDA -5% YoY to -$21.2M.

Guidance / outlook

The Company expects the actions to generate approximately $12 million in annualized operating expense savings once fully implemented.

Earnings release Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Prediction-grade evidence

Recent News

Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

Earnings Per Share

Score 4.00/5
QuantumSi Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Biotechnology industry , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated , Exelixis Inc are companies with high ratings.

Return on Equity

Score 1.71/5
QuantumSi Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
QuantumSi In... QSI US$171.0m
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Net Margin

Score 0.28/5
QuantumSi Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
QuantumSi In... QSI US$171.0m
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Share Buyback

In Biotechnology industry , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated , Exelixis Inc are companies with high ratings.

Leverage

Score 3.97/5
QuantumSi Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
QuantumSi In... QSI US$171.0m
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

Reported currency
Verified SEC statements load when this section enters view.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

QuantumSi Inc logo

QuantumSi Inc

US$0.744

US$171.0m

-8.61%

-33.54%